December 20, 2012 Trading Market Activity

Before you go, we thought you'd like these...
Before you go close icon

December 20, 2012 Trading Market Activity

BUFORD, Ga.--(BUSINESS WIRE)-- Theragenics Corporation (NYS: TGX) , a medical device company serving the surgical products and prostate cancer treatment markets, announced today that in view of the market activity in the Company's stock on Thursday, December 20, 2012, the New York Stock Exchange contacted the Company on December 24, 2012, in accordance with the Exchange's usual practice. The Company stated that its policy is not to comment on market activity.

Theragenics Corporation (NYS: TGX) operates two business segments: its surgical products business and its brachytherapy seed business. The surgical products business (www.cpmedical.com, www.galtmedical.com, www.needletech.com) manufactures and distributes wound closure, vascular access, and specialty needle products. Wound closure products include sutures, needles and other surgical products. Vascular access includes introducers, guidewires and related products. Specialty needles include coaxial, biopsy, spinal and disposable veress needles, access trocars, RF devices, implanters, introducer products and other needle-based products. The surgical products segment serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. Theragenics' brachytherapy business manufactures, markets and distributes "seeds" used primarily in the minimally invasive treatment of localized prostate cancer. The Company's brachytherapy product line includes its palladium-103 TheraSeed® device and its iodine-125 AgX100™ device (www.theragenicsbrachy.com). The terms "Company," "we," "us," or "our" mean Theragenics Corporation and all entities included in our consolidated financial statements. For additional information, call our Investor Relations Department at (800) 998-8479 or visit www.theragenics.com.


All forward looking statements and cautionary statements included in this document are made as of the date hereof based on information available to us as of the date hereof, and we assume no obligation to update any forward looking statement or cautionary statement.

anImage


Theragenics Corporation
Frank Tarallo, 800-998-8479 or 770-271-0233
CFO and Treasurer
or
Lisa Rassel, 800-998-8479 or 770-271-0233
Manager of Investor Relations
rassell@theragenics.com
www.theragenics.com

KEYWORDS:   United States  North America  Georgia

INDUSTRY KEYWORDS:

The article December 20, 2012 Trading Market Activity originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners